Defend a .uk domain acquired as an investment: what panels actually decide
A brand owner files a Nominet DRS complaint against a domain you registered years ago as part of an investment portfolio. The name has generic or descriptive qualities. You have held it quietly, perhaps parked it, and never targeted the complainant. Now you face a transfer order unless you respond effectively. The question is not simply whether you win or lose – it is what evidence and arguments actually move a Nominet expert, and what the realistic outcomes look like when you defend a .uk domain acquired as an investment.
Under the Nominet DRS, a domain is transferred or suspended only when the complainant proves both rights in a name and an abusive registration or use – the key word is "or," meaning the test can be met even if your registration was entirely innocent but your subsequent conduct became abusive. In our practice defending .uk domain investors, that disjunctive standard is the most misunderstood feature of the Nominet rules. It is also the most important one to address from the first line of your response.
This analysis covers the governing DRS test, how panels read investment registrations, the evidence record that decides most cases, the minority and consensus panel positions on common fact patterns, and where an RDNH-equivalent finding becomes realistic.
How does the Nominet DRS test differ from the UDRP, and why does it matter for an investor?
The Nominet DRS applies its own "abusive registration" test, not the UDRP's three-element formula – and the difference is material for anyone who registered a .uk domain as a business asset rather than to target a specific brand owner. Under the UDRP, a complainant must prove the domain was registered and is used in bad faith: both elements, cumulatively. Under the Nominet DRS, the test is registration or use that took unfair advantage of, or was unfairly detrimental to, the complainant's rights. That disjunction means a domain that was registered in complete good faith can still be the subject of a successful DRS complaint if the registrant's subsequent conduct – pointing it at a pay-per-click page that exploits the complainant's mark, for instance – is found to be abusive.
For an investor holding a portfolio of generic or short .uk domains, this has a concrete implication. Passive holding is generally neutral on the DRS record. Parking that generates revenue specifically from traffic associated with a complainant's brand is not. The distinction sounds obvious, but panels examine the monetization configuration at the time of the complaint, not just the original registration intent. We regularly advise registrants who correctly registered a name years before any complainant's mark existed, only to face a DRS complaint because the parking page pulled in advertising categories that matched the complainant's product line.
A second structural difference: the Nominet DRS includes a free mediation stage before any expert decision is issued. Where a response is filed, the parties are automatically opted into mediation. This creates a negotiated exit that the UDRP does not offer at the same stage. For an investor whose primary goal is to realize value from the domain rather than hold it indefinitely, mediation is sometimes the most commercially rational path – but only if the underlying DRS defense is strong enough to give the complainant reason to negotiate.
For a read on whether the abusive-registration test applies to your .uk domain, reach us at info@cognomenlaw.com.
What does "abusive registration" actually mean when you register a .uk domain as an investment?
The consensus position among Nominet experts is that registering a domain as a generic or descriptive asset – without targeting a specific brand or trademark owner – is not inherently abusive, even if a complainant subsequently acquires trademark rights in a similar term. Timing matters enormously. A domain registered before the complainant's mark became distinctive is very difficult to characterize as abusive at the point of registration. What panels look for is whether, at the moment of registration, the registrant was aware of the complainant's rights and registered the name specifically to exploit them.
Three fact patterns come up repeatedly in the DRS case record, and panels apply them with reasonable consistency. First: prior rights and timing. If the registration predates the complainant's trademark or brand build-out, the registrant starts from a favorable position on the "abusive registration" limb. Second: awareness at the time of registration. If the complainant's mark was well-known in the relevant market at the date of registration, a panel may infer that the registrant – particularly one operating a professional domain portfolio – was aware of it. Third: commercial motive versus targeting. Registering a short, generic .uk string because it has inherent commercial value is different from registering it because a specific brand owner wants it. Panels are reasonably good at identifying which situation they are looking at, though a large portfolio covering many industries can be harder to read cleanly.
The minority view – not the consensus, but present in a subset of DRS decisions – is that a sophisticated domain investor operating at scale is held to a higher standard of diligence. Under this view, a professional registrant who operates hundreds or thousands of .uk domains and registers one that happens to conflict with a growing brand cannot always claim ignorance as convincingly as an individual who registered a single name for personal use. This minority position has not hardened into a rule, but it surfaces most often where the registrant has acquired a domain after the complainant's mark became publicly known and commercially significant.
How do you build the legitimate-interest record for a .uk investment domain?
Unlike the UDRP, the Nominet DRS does not use the phrase "rights or legitimate interests" with safe-harbor sub-paragraphs mirroring Paragraph 4(c). The DRS instead asks whether the registrant's registration or use is abusive – and the registrant's defense is effectively to negate that characterization by demonstrating that the registration had a plausible, non-brand-targeting rationale and that use (if any) has been consistent with that rationale.
In practice, the evidence types that persuade Nominet experts fall into several categories. Registration date and context: a contemporaneous record of why the domain was acquired – a portfolio acquisition memo, a secondary-market invoice, registration of similar generic strings around the same date – is highly useful. It establishes the investment rationale in a document that predates the dispute. Generic or descriptive character of the name: if the string has an ordinary English meaning, that supports a non-targeting interpretation. Where the domain is an acronym or a coined term identical to the complainant's trademark, that defense is harder to sustain. Prior dispute history: a clean DRS record across a portfolio counts in favor of the registrant. A pattern of registering brand-matching strings across multiple rights holders, by contrast, is a strongly negative factor that panels cite as evidence of a systematic scheme.
Monetization configuration is the area where otherwise strong defenses most often unravel. A parked page that pulls advertising from categories linked to the complainant's industry does not prove registration was abusive, but it provides compelling evidence that use became abusive after the fact. If the parking revenue was derived from categories unrelated to the complainant's field – or if the domain was held completely passively with no parking – that is worth documenting explicitly in the response. We have defended portfolio registrants who had no idea what their parking aggregator was displaying; the panel's concern is the objective effect of the page on a consumer, not the registrant's subjective knowledge of every ad category.
The response filing itself is the single most important moment in the DRS process. A default – where the registrant fails to respond – results in a summary decision that almost invariably goes against the registrant. Filing a substantive response triggers the mediation stage and forces the complainant to engage with a contested process. Even a response that does not ultimately succeed at the expert stage can produce a mediated outcome that is commercially better than a transfer order.
What evidence decides the outcome most often in practice?
Nominet experts are generally experienced intellectual property practitioners appointed for specific cases. They read the record closely. The evidence that demonstrably shifts outcomes – in both directions – clusters around a handful of categories.
For the respondent, the most powerful evidence is temporal: the closer the registration date is to a period before the complainant's brand became known, the less room there is to characterize the registration as targeting. Secondary market acquisition records matter here, because a domain bought on the aftermarket years after initial registration raises the question of what the buyer knew at the point of purchase. In a recent matter (a portfolio of short .uk generics, spring 2025), we successfully defended a transfer by producing secondary-market acquisition records, a contemporaneous portfolio strategy document, and evidence that the parking configuration had been set up across the entire portfolio uniformly – not targeted at the complainant's category. The expert accepted that the domain fell within the registrant's legitimate investment activity.
For the complainant, the most powerful evidence is a pattern. A registrant who has registered multiple variations of the same brand name, in multiple zones, across a short timeframe, faces a near-impossible task explaining why each one was independently motivated by the generic value of the string. That pattern evidence can convert an otherwise defensible case into a losing one quickly. Panels cite it as an indicator of abusive intent under the DRS indicators of abusive registration.
A third category that decides marginal cases is correspondence. Approaches to the complainant offering to sell the domain at a price that bears no relationship to registration costs – particularly where the price quoted is tied to the complainant's known revenues or valuation – are treated as strong evidence of abusive intent. This does not mean that a domain investor can never discuss price with a brand owner; it means that the framing and timing of those discussions matter greatly, and that an approach made after the investor became aware of the brand owner's interest in the name reads very differently from an unsolicited speculative offer made before any rights assertion.
If you have received a DRS complaint or a cease-and-desist concerning a .uk investment domain, email info@cognomenlaw.com to assess your response options before the 20-day deadline runs.
When is an RDNH-equivalent finding realistic under the Nominet DRS?
The Nominet DRS recognizes reverse domain name hijacking, meaning a finding that the complaint was brought in bad faith to deprive a legitimate registrant of the domain. The finding is reputational rather than monetary – no costs order flows from it – but it carries weight as a deterrent and as a matter of public record. It also shifts the commercial dynamic, because a brand owner who has publicly been found to have filed an abusive complaint is less likely to persist with a follow-on strategy in other zones.
In our practice, the conditions for an RDNH finding under the DRS are more demanding than in many UDRP proceedings. Nominet experts tend to require a clear demonstration that the complainant knew the complaint was not maintainable when filed, or that it was deployed as a pressure tactic against a registrant with an obviously strong defense. The most common situations where RDNH is found in the DRS context are: a complainant whose trademark rights postdate the registration by a wide margin and who filed without acknowledging that gap; a complainant who pursued a clearly generic domain whose commercial value has nothing to do with the complainant's brand; and a complainant who made settlement demands that effectively required the registrant to waive a valid defense as a condition of receiving any compensation.
The realistic assessment is this: RDNH findings in the Nominet DRS are available but infrequent. If the complainant has any arguable case – even a weak one – a panel is unlikely to call it abusive. The threshold is demonstrable bad faith in filing, not mere failure on the merits. A respondent who wins on the DRS test but does not separately establish that the complaint was brought in bad faith will not receive an RDNH finding. That said, in cases where the evidence of a strong registration-predating-trademark is combined with a complainant who had legal advice and must have known the timeline, the argument is worth making explicitly and the available DRS decisions on the point are worth citing.
How does the .uk defense compare to defending a parallel UDRP over the same name in another zone?
A brand owner targeting a domain investor often does so across multiple zones simultaneously – a UDRP complaint against the .com alongside a Nominet DRS complaint against the .uk. The two proceedings run independently under different rules, with different timelines and different legal tests. Getting that interaction right is one of the more complex aspects of multi-zone portfolio defense.
On the legal test, the key divergence is the disjunctive "or" in the DRS versus the cumulative "and" in the UDRP. A defense that prevails under the UDRP – proving registration was in good faith even if current use is passive – may not be sufficient under the DRS if current use is found to be abusive. Conversely, a DRS defense that relies on the descriptive character of the .uk string may face a harder path under the UDRP if the complainant's mark is registered and the domain is identical.
On timing, a Nominet DRS case typically runs about 8–12 weeks, including the mediation stage, and an appeal to a three-expert panel is available within 10 working days of a decision. A standard UDRP proceeding runs approximately two months from filing. The two proceedings can therefore deliver conflicting results within weeks of each other, which creates a complicated record if the investor later pursues litigation or a further challenge.
On cost structure, the Nominet DRS is materially lower in official fees than the UDRP. Where a response is filed, Nominet's expert decision fee is GBP 750 plus VAT for a full contested decision. A three-expert appeal costs GBP 3,000 plus VAT. Legal fees for preparing a substantive response are additional and vary with the complexity of the portfolio record. By comparison, the WIPO filing fee for a single-domain, single-panel UDRP starts at USD 1,500, with the complainant generally bearing that cost. The cross-zone picture means that an investor defending both zones simultaneously is managing two separate proceedings, two separate evidence records, and two potential outcomes that may diverge on the same underlying facts.
Where the investor's portfolio includes domains in further zones – .eu, .de, .com – the analysis extends still further. A .eu complaint proceeds under the ADR.eu procedure at the Czech Arbitration Court, with its own eligibility and remedy rules. A .de name has no UDRP equivalent: disputes go to the German courts, with a DENIC DISPUTE entry available to block transfer while the claim is active. In those situations, coordinating the response strategy across forums – so that admissions or concessions in one filing do not undercut the defense in another – is a material part of the work we undertake for portfolio registrants.
What are the realistic outcomes, and what should an investor do now?
Dismissal – a panel finding that the complainant has not met the DRS test – preserves the domain and produces a public record that can deter future complainants. It does not generate costs or damages for the registrant, but it resolves the dispute cleanly. This is the best outcome for an investor who wants to hold the name.
Mediated settlement is commercially available at the stage before an expert decision is issued. It is worth considering when the legal position is strong but not certain, when the name's value lies primarily in its sale potential rather than long-term holding, or when multi-zone litigation is a disproportionate cost relative to the asset value. A mediated transfer at market value is a different outcome from a panel-ordered transfer with no payment; investors sometimes conflate the two when reading about DRS results. They are procedurally distinct paths.
A panel-ordered transfer is the outcome if the complainant meets the DRS test and mediation fails or is not pursued. The expert's decision is published. An appeal is available to either party within 10 working days, to a three-expert panel that rarely admits new evidence. The appeal costs GBP 3,000 plus VAT. Appeals are available but succeed only where the first-instance expert made a clear error on the DRS test; they are not a routine second bite.
The myth we encounter most often in this area is that a domain registered before a complainant's trademark was filed is automatically safe under the Nominet DRS. That is not the law. A registration that predates a mark is strong evidence against abusive registration, but it is not a complete defense if current use is independently found to be abusive. An investor who registered a domain in good faith five years ago but has since monetized it in a way that exploits the complainant's brand faces a real risk even with a compelling registration story. The full record – not just the registration date – determines the outcome.
In a second recent matter (a .uk acronym domain, autumn 2025), a complainant with a registered trademark and a growing commercial profile filed a DRS complaint against a portfolio registrant who had held the name passively for several years. We built the response around contemporaneous portfolio documents, the domain's independent descriptive value, and the absence of any targeting conduct. The expert dismissed the complaint. No RDNH finding was made – the complainant had a colorable case on the rights limb – but the registration was found not to have been abusive on either the registration or the use limb.
Related at COGNOMEN
Frequently asked questions
How do I start to defend a .uk domain acquired as an investment?
The first step is to review the DRS complaint carefully and identify which limb of the abusive-registration test the complainant relies on – registration, use, or both. You then have 20 days from commencement to file a response; filing is critical because a default almost always results in a summary decision against the registrant. Gather registration records, portfolio documentation, parking or use records, and any correspondence with the complainant. Legal advice at this stage, before filing a response, is strongly advisable. Contact info@cognomenlaw.com to assess the position.
What are the realistic outcomes when you defend a .uk domain acquired as an investment?
There are three main outcomes: dismissal (the expert finds the complainant has not met the DRS test and the domain stays with the registrant), mediated settlement (the parties reach a commercial resolution at the pre-decision mediation stage), or a transfer order (the expert upholds the complaint). A fourth outcome – an RDNH-equivalent finding – is available but requires demonstrating that the complaint was filed in bad faith, not merely that the complainant failed on the merits. No monetary damages flow from any DRS outcome.
How do fees split if the case escalates?
Where a response is filed and mediation fails or is waived, the complainant pays Nominet's expert decision fee of GBP 750 plus VAT for a full first-instance decision. If either party appeals, the appeal fee is GBP 3,000 plus VAT, borne by the party filing the appeal. Legal fees for preparing the response and any appeal submissions are separate from these official fees and depend on the complexity of the evidence record. In a parallel UDRP over the same brand in another zone, the complainant bears the WIPO filing fee starting at USD 1,500 for a single-panel case.
Author: Anton Grant — Respondent defense and reverse domain name hijacking (RDNH). Meet the team.
Speak with Cognomen Law
For a scoped view of your domain matter, contact info@cognomenlaw.com. Discuss your matter
This publication is general information and does not constitute legal advice. For advice on your situation, contact info@cognomenlaw.com.